This presentation describes the artemisinin combination therapies in MMV's pipeline, the drugs of different classes that are also in development, and some of the approaches taken to identifying and developing new drugs.
Presentation from MMV-CRESIB Forum, Barcelona, Spain, 15 March 2010. Medicines for Malaria Venture, Geneva, Switzerland. 17 pp.
Looking to the future: MMV’s discovery and development priorities for malaria eradication